TARS
Tarsus·NASDAQ
--
--(--)
--
--(--)
TARS Filings
Filing Date
Form Description
Form Type
2025-12-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 144 - Report of proposed sale of securities
Ownership
2025-12-16 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-16
Form 144 - Report of proposed sale of securities
Ownership
2025-12-16 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-15
Form 144 - Report of proposed sale of securities
Ownership
2025-12-15 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-15
Form 144 - Report of proposed sale of securities
Ownership
2025-12-15 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-08
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-08 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-04
Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-04 · Earnings Call
Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call Transcript
2025-11-04
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-04 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
